{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:42:21Z","timestamp":1791848541345,"version":"4.3.4"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"abstract":"<jats:p>Brucellosis is a zoonotic disease caused by Brucella. There is no effective vaccine against human brucellosis. Omp19 and Omp25 are the outer membrane proteins of Brucella. They are widely expressed and highly conserved in Brucella and have high immunogenicity. Herein, we aim to identify multi-epitope vaccine candidates based on Omp19 and Omp25. We analyzed the physicochemical properties and protein structure of Omp19 and Omp25, and predicted the corresponding B cell and T cell epitopes using bioinformatics analysis. Omp19 and Omp25 were composed of 177 amino acids and 213 amino acids, respectively. They were both stable hydrophilic proteins. The instability indices were 44.8 and 23, respectively. The hydrophilicity was \u22120.1 and \u22120.317, respectively. In the secondary structure of Omp19 and Omp25 proteins, the \u03b1-helix accounted for 12.43% and 23.94%, the \u03b2-sheet was 18.64% and 23.47%, the \u03b2-turn was 6.78% and 4.23%, and the random coil was 62.15% and 48.36%. Finally, 5 B cell epitopes, 3 Th-cell epitopes and 5 CTL cell epitopes of Omp19 protein, and 4 B cell epitopes, 3 Th-cell epitopes, and 5 CTL cell epitopes of Omp25 protein were selected as vaccine candidates. In conclusion, we obtained potential B cell and T cell epitopes of the Brucella outer membrane Omp19 and Omp25 proteins. This lays the foundation for the further design of multi-epitope vaccine of Brucella.<\/jats:p>","DOI":"10.1097\/md.0000000000033182","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:05:54Z","timestamp":1679069154000},"page":"e33182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Bioinformatics analysis of Omp19 and Omp25 proteins for designing multi-epitope vaccines against Brucella"],"prefix":"10.1097","volume":"102","author":[{"given":"Donghao","family":"Shi","sequence":"first","affiliation":[{"name":"Clinical Laboratory Center, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Center, People`s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzhi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Public Health, People`s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feili","family":"Xu","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Center, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Urumqi OE Biotech Co., Ltd., Urumqi, Xinjiang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmin","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Center, People`s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8373-8304","authenticated-orcid":false,"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Laboratory Center, People`s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1017\/S0950268815002575","article-title":"Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection.","volume":"144","author":"Musallam","year":"2016","journal-title":"Epidemiol Infect"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.meegid.2016.07.025","article-title":"Genotyping of Brucella melitensis and Brucella abortus strains currently circulating in Xinjiang, China.","volume":"44","author":"Sun","year":"2016","journal-title":"Infect Genet Evol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.molimm.2019.09.013","article-title":"Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella.","volume":"114","author":"Li","year":"2019","journal-title":"Mol Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.12691\/ajeid-5-2-2","article-title":"Public health and economic importance of bovine brucellosis: an overview.","volume":"5","author":"Pal","year":"2017","journal-title":"Am J Epidemiol Infect Diseases"},{"key":"R5-20250504","first-page":"e1929e1929","article-title":"Clinical manifestations of human brucellosis: a systematic review and meta-analysis.","volume":"6","author":"Dean","year":"2012","journal-title":"PLoS NeglTrop Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","article-title":"Development and trial of vaccines against Brucella.","volume":"18","author":"Lalsiamthara","year":"2017","journal-title":"J Vet Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development.","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol (Beijing)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18869\/modares.iem.2.4.32","article-title":"Vaccines and vaccine candidates against brucellosis.","volume":"2","author":"Mansoori","year":"2016","journal-title":"Infect Epidemiol Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prevetmed.2004.03.007","article-title":"The \u201ceffects\u201d of Rev-1 vaccination of sheep and goats on human brucellosis in Greece.","volume":"64","author":"Minas","year":"2004","journal-title":"Prev Vet Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/CVI.00419-08","article-title":"Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes.","volume":"16","author":"Olsen","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.meegid.2017.04.009","article-title":"Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.","volume":"51","author":"Saadi","year":"2017","journal-title":"Infect Genet Evol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines.","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/vaccines7030088","article-title":"Immunoinformatics-aided design and evaluation of a potential multi-epitope vaccine against Klebsiella pneumoniae.","volume":"7","author":"Dar","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/abbs\/gmu016","article-title":"A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.","volume":"46","author":"Tu","year":"2014","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11259-015-9645-2","article-title":"Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.","volume":"39","author":"Abkar","year":"2015","journal-title":"Vet Res Commun"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e16203","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.","volume":"6","author":"Pasquevich","year":"2011","journal-title":"PLoS One"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fimmu.2017.00708","article-title":"Brucella Omp25 Upregulates miR-155, miR-21-5p, and miR-23b to Inhibit Interleukin-12 production via modulation of programmed death-1 signaling in human monocyte\/macrophages.","volume":"8","author":"Cui","year":"2017","journal-title":"Front Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","article-title":"The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.","volume":"25","author":"Commander","year":"2007","journal-title":"Vaccine"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects BALB\/c mice from virulent B. abortus 544.","volume":"51","author":"Goel","year":"2012","journal-title":"Mol Immunol"},{"key":"R22-20250504","first-page":"681","article-title":"SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments.","volume":"11","author":"Geourjon","year":"1995","journal-title":"Comput Appl Biosci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","article-title":"The SWISS-MODEL repository-new features and functionality.","volume":"45","author":"Bienert","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes.","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network.","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00726-006-0485-9","article-title":"Prediction of linear B-cell epitopes using amino acid pair antigenicity scale.","volume":"33","author":"Chen","year":"2007","journal-title":"Amino Acids"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1472-6807-7-64","article-title":"Antibody-protein interactions: benchmark datasets and prediction tools evaluation.","volume":"7","author":"Ponomarenko","year":"2007","journal-title":"BMC Struct Biol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2680160","DOI":"10.1155\/2017\/2680160","article-title":"Fundamentals and methods for T- and B-cell epitope prediction.","volume":"2017","author":"Sanchez-Trincado","year":"2017","journal-title":"J Immunol Res"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinf"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"e13458","DOI":"10.1371\/journal.pone.0013458","article-title":"Allele polymorphism and haplotype diversity of HLA-A, -B and -DRB1 loci in sequence-based typing for Chinese Uyghur ethnic group.","volume":"5","author":"Shen","year":"2010","journal-title":"PLoS One"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"249","DOI":"10.20506\/rst.32.1.2197","article-title":"Economics of brucellosis impact and control in low-income countries.","volume":"32","author":"McDermott","year":"2013","journal-title":"Rev Sci Tech"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.meegid.2017.09.015","article-title":"Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.","volume":"55","author":"Vishnu","year":"2017","journal-title":"Infect Genet Evol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.meegid.2016.12.010","article-title":"Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus.","volume":"48","author":"Hajighahramani","year":"2017","journal-title":"Infect Genet Evol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2016.5.1.50","article-title":"A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach.","volume":"5","author":"Karkhah","year":"2016","journal-title":"Clin Exp Vaccine Res"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.humimm.2019.02.008","article-title":"A multiepitopic theoretical fusion construct based on in-silico epitope screening of known vaccine candidates for protection against wide range of enterobacterial pathogens.","volume":"80","author":"Kumar","year":"2019","journal-title":"Hum Immunol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bj.2018.04.007","article-title":"In silico prediction of T- and B-cell epitopes in PMPD: first step towards to the design of a Chlamydia trachomatis vaccine.","volume":"41","author":"Russi","year":"2018","journal-title":"Biomed J"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0378-1135(02)00222-5","article-title":"Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection.","volume":"90","author":"Baldwin","year":"2002","journal-title":"Vet Microbiol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e34246","DOI":"10.1371\/journal.pone.0034246","article-title":"Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies.","volume":"7","author":"Qiu","year":"2012","journal-title":"PLoS One"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetmic.2016.10.027","article-title":"Comparison of potential protection conferred by three immunization strategies (protein\/protein, DNA\/DNA, and DNA\/protein) against Brucella infection using Omp2b in BALB\/c Mice.","volume":"197","author":"Golshani","year":"2016","journal-title":"Vet Microbiol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.18632\/oncotarget.24073","article-title":"Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity.","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.","volume":"33","author":"Ghasemi","year":"2015","journal-title":"Vaccine"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3389\/fmicb.2018.02230","article-title":"Characterization of cell envelope multiple mutants of brucella ovis and assessment in mice of their vaccine potential.","volume":"9","author":"Sidhu-Munoz","year":"2018","journal-title":"Front Microbiol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/1735-5362.192493","article-title":"Cloning, expression and molecular analysis of Iranian Brucella melitensis Omp25 gene for designing a subunit vaccine.","volume":"11","author":"Yousefi","year":"2016","journal-title":"Res Pharm Sci"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/IAI.69.8.4823-4830.2001","article-title":"Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.","volume":"69","author":"Jubier-Maurin","year":"2001","journal-title":"Infect Immun"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","article-title":"Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.","volume":"31","author":"Goel","year":"2013","journal-title":"Vaccine"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2018.04.002","article-title":"Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.","volume":"99","author":"Paul","year":"2018","journal-title":"Mol Immunol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08830185.2019.1657426","article-title":"Immunoinformatics: in silico approaches and computational design of a multi-epitope, immunogenic protein.","volume":"38","author":"Bahrami","year":"2019","journal-title":"Int Rev Immunol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes.","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jmr.893","article-title":"Predicting linear B-cell epitopes using string kernels.","volume":"21","author":"El-Manzalawy","year":"2008","journal-title":"J Mol Recognition"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1389201014666131226123016","article-title":"Research progress in live attenuated Brucella vaccine development.","volume":"14","author":"Wang","year":"2013","journal-title":"Curr Pharm Biotechnol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-60327-118-9_5","article-title":"SYFPEITHI: database for searching and T-cell epitope prediction.","volume":"409","author":"Schuler","year":"2007","journal-title":"Methods Mol Biol"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2019.04.030","article-title":"In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma.","volume":"112","author":"Safavi","year":"2019","journal-title":"Mol Immunol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/21645515.2020.1763693","article-title":"Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model.","volume":"17","author":"Safavi","year":"2021","journal-title":"Hum Vaccin Immunother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:12:21Z","timestamp":1746328341000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033182","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}